European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Pulmonary Hypertension (Guidelines on Diagnosis and Treatment of)

ESC Clinical Practice Guidelines

Topics: Pulmonary Hypertension

Summary

ESC Congress 2009 video: ESC Guidelines New!

Watch a video about the new ESC Guidelines presented at the ESC Congress 2009

03/02/2009 00:00:00

Current versions available to download

Publication dateVersionsReferencesSize
 Essential MessagesEssential Messages Pulmonary Hypertension855 KB
 Corrigendumdoi:10.1093/eurheartj/ehr04626 KB
2009Full TextEuropean Heart Journal (2009) 30, 2493–2537; doi:10.1093/eurheartj/ehp297
 Pocket GuidelinesPocket Guidelines PH TOC
  Slide-setGuidelines slides on Pulmonary Hypertension12 MB
 CME QuestionsCME Questions - Pulmonary Hypertension

Current translated versions available to download:

Authors

Nazzareno Galie (Chairperson) ; Marius M. Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J. Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko ; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Withdrawal of sitaxentan in the treatment of pulmonary arterial hypertension

 

 

 

 

 

 

 

 

 

Endorsed by:

Table of contents: Full Text (ESC Clinical Practice Guidelines)

Part 1 to 6

  • Preamble
  • Introduction
  • Definitions
  • Clinical classification of pulmonary hypertension
  • Pathology of pulmonary hypertension
  • Pathobiology of pulmonary hypertension
  • Genetics, epidemiology, and risk factors of pulmonary hypertension

Part 7.Pulmonary arterial hypertension (Group 1)

  • Diagnosis
  • Evaluation of severity
  • Therapy
  • Specific pulmonary aterial hypertension susbsets

Part 8.Pulmonary veno-occlusive disease & pulmonary capillary haemangiomatosis

  • Pulmonary veno-occlusive disease
  • Pulmonary capillary haemangiomatosis

Part 9 to 12

  • Pulmonary hypertension due to left heart disease (group 2)
  • Pulmonary hypertension due to lung diseases and:or hypoxamia (group 3)
  • Chronic thromboembolic pulmonary hypertension (group 4)
  • Definition of a pulmonary arterial hypertension referral centre

Previous versions

A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here

2004  Pulmonary Arterial Hypertension EHJ Full Text